<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 4, 2001
INSMED INCORPORATED
(Exact name of registrant as specified in its charter)
<TABLE>
<S><C>
VIRGINIA 0-30739 54-1972729
-------------------------------------------------------------------------------------------------------------------
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation) Identification No.)
</TABLE>
800 East Leigh Street, Richmond, VA 23219
(Address of principal executive offices and zip code)
Registrant's telephone number, including area code: (804) 828-6893
<PAGE>
ITEM 5. OTHER EVENTS
On January 4, 2001, Insmed Incorporated issued a press release
announcing the results following a full analysis of its recently
completed clinical trial of Type 2 diabetes patients treated with
INS-1 in combination with sulfonylureas. Insmed also announced in
the press release that Insmed's management team will host a
conference call on Friday, January 5 at 8:00 a.m. EST to discuss
these results. The dial-in number is 800-289-0437 (domestic) or
913-981-5508 (international). The reference code is 509579. A
replay of the call will be available from 11:00 a.m. EST, Friday,
January 5 through 11:00 a.m. EST, Friday, January 12, 2001. The
replay dial-in number is 888-203-1112 (domestic) or 719-457-0820
(international). A copy of the press release is attached hereto as
Exhibit 99.1 and is incorporated herein by reference. The press
release was also posted on Insmed's website on January 4, 2001.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(c) Exhibit
99.1 Press Release dated January 4, 2001.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
INSMED INCORPORATED
Date: January 4, 2001 By: /s/ Michael D. Baer
---------------------
Michael D. Baer
Chief Financial Officer
<PAGE>
INSMED INCORPORATED
INDEX TO EXHIBITS
Exhibit Number
99.1 Press Release dated January 4, 2001.
